2-aminoindan

**2-aminoindan** is a small organic compound belonging to the indane class and is structurally characterized by an indane ring fused to a primary amino group at the 2-position[1][4][8]. It is a bicyclic analogue of amphetamine, structurally similar but with distinctly different biological effects. 2-aminoindan has been studied as an inhibitor of dopamine β-hydroxylase—a key enzyme converting dopamine to norepinephrine[1]. Preclinical pharmacology has documented its serotonergic activity: it may act as a releasing agent for serotonin and possibly influence dopamine and norepinephrine reuptake, producing mild entactogenic and empathogenic effects[7][9]. Its psychoactive activity, bronchodilating, and analgesic properties have been investigated, mainly in research and as part of the human exposome following environmental exposure[7][4][9]. 2-aminoindan is widely used as a chemical building block in organic synthesis and in the development of molecules targeting neurological disorders, but is not used in mainstream clinical practice or as an approved pharmaceutical[6]. It is mainly a research chemical and has appeared in designer drug markets. There is no evidence of marketing by pharmaceutical companies, nor clear clinical development for therapeutic indications[9].

Other names

2-aminoindane(2,3-dihydro-1H-inden-2-yl)amine1H-inden-2-amine, 2,3-dihydro-2,3-dihydro-1H-inden-2-amine2-amino-2,3-dihydro-1H-indene2-indanamine2-indanylamine